32
Participants
Start Date
March 26, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
December 31, 2026
STSP-0601 for Injection
Evaluation of the Efficacy of Single-Dose and Continuous Administration of STSP-0601 Injection for the Treatment of Bleeding in Patients with Hemophilia A or B with Inhibitors
NOT_YET_RECRUITING
Harbin First Hospital Hematology Tumor Research Center, Harbin
NOT_YET_RECRUITING
Jiangsu Provincial Hospital, Nanjing
NOT_YET_RECRUITING
Anhui Provincial Hospital, Hefei
NOT_YET_RECRUITING
Jinan Central Clinical College of Shandong First Medical University, Jinan
NOT_YET_RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
Hospital of Hematology, Chinese Academy of Medical Sciences, Tianjin
NOT_YET_RECRUITING
Wenzhou People's Hospital, Wenzhou
NOT_YET_RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
NOT_YET_RECRUITING
Shenzhen Second People's Hospital, Shenzhen
NOT_YET_RECRUITING
The First affiliated hospital of Guangxi Medical University, Nanning
NOT_YET_RECRUITING
Sichuan Academy of Medical Sciences＆Sichuan Provincial People's Hospital, Chengdu
NOT_YET_RECRUITING
The Second Affiliated Hospital of Kunming Medical University, Kunming
NOT_YET_RECRUITING
Xi'an Central Hospital, Xi’an
NOT_YET_RECRUITING
Lanzhou University First Hospital, Lanzhou
NOT_YET_RECRUITING
North China University of Science and Technology Affiliated Hospital, Tangshan
NOT_YET_RECRUITING
Second hospital of Shanxi Medical University, Taiyuan
Jiangsu BioJeTay Biotechnology Co., Ltd.
INDUSTRY